<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Rats with experimental <z:hpo ids='HP_0002583'>colitis</z:hpo> suffer from impaired gastric emptying (GE) </plain></SENT>
<SENT sid="1" pm="."><plain>We previously showed that this phenomenon involves afferent neurons within the pelvic nerve </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we aimed to identify the mediators involved in this afferent hyperactivation </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0002583'>Colitis</z:hpo> was induced by <z:chebi fb="0" ids="48110">trinitrobenzene</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> (<z:chebi fb="0" ids="53063,53506">TNBS</z:chebi>) instillation </plain></SENT>
<SENT sid="4" pm="."><plain>We determined GE, distal front, and geometric center (GC) of intestinal transit 30 min after intragastric administration of a semiliquid Evans blue solution </plain></SENT>
<SENT sid="5" pm="."><plain>We evaluated the effects of the transient receptor potential vanilloid type 1 (TRPV1) <z:chebi fb="68" ids="48706">antagonists</z:chebi> capsazepine (5-10 mg/kg) and N-(4-tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine-1(2H)<z:chebi fb="0" ids="23004,37622">carboxamide</z:chebi> (BCTC; 1-10 mg/kg) and the calcitonin gene-related <z:chebi fb="7" ids="16670">peptide</z:chebi> (CGRP) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> CGRP-(8-37) (150 microg/kg) </plain></SENT>
<SENT sid="6" pm="."><plain>To determine TRPV1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> sensitivity, we examined their effect on <z:chebi fb="8" ids="3374">capsaicin</z:chebi>-induced relaxations of isolated gastric fundus muscle strips </plain></SENT>
<SENT sid="7" pm="."><plain>Immunocytochemical staining of TRPV1 and RT-PCR analysis of TRPV1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> were performed in dorsal root ganglion (DRG) L6-S1 </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="53063,53506">TNBS</z:chebi>-induced <z:hpo ids='HP_0002583'>colitis</z:hpo> reduced GE but had no effect on intestinal motility </plain></SENT>
<SENT sid="9" pm="."><plain>Capsazepine reduced GE in controls but had no effect in rats with <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>At doses that had no effects in controls, BCTC and CGRP-(8-37) significantly improved <z:hpo ids='HP_0002583'>colitis</z:hpo>-induced <z:hpo ids='HP_0002578'>gastroparesis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Capsazepine inhibited <z:chebi fb="8" ids="3374">capsaicin</z:chebi>-induced relaxations by 35% whereas BCTC completely abolished them </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="53063,53506">TNBS</z:chebi>-induced <z:hpo ids='HP_0002583'>colitis</z:hpo> increased TRPV1-like immunoreactivity and TRPV1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> content in pelvic afferent neuronal cell bodies in DRG L6-S1 </plain></SENT>
<SENT sid="13" pm="."><plain>In conclusion, distal <z:hpo ids='HP_0002583'>colitis</z:hpo> in rats impairs GE via sensitized pelvic afferent neurons </plain></SENT>
<SENT sid="14" pm="."><plain>We provided pharmacological, immunocytochemical, and molecular biological evidence that this sensitization is mediated by TRPV1 receptors and involves CGRP release </plain></SENT>
</text></document>